Table 7. Comparison of disease progression between patients with PLA2R-Ab ≤ 97.6 RU/ml and > 97.6 RU/ml.
| PLA2R-Ab ≤ 97.6 RU/ml (N = 26) | PLA2R-Ab > 97.6 RU/ml (N = 26) | ||||
|---|---|---|---|---|---|
| n (%) | |||||
| n* | n* | p-value | |||
| CKD ≥ 4 | 26 | 26 | 0.0022 | ||
| No | . | 25 (96.2) | . | 16 (61.5) | . |
| Yes | . | 1 (3.8) | . | 10 (38.5) | . |
| Remission | 26 | 26 | 0.0011 | ||
| No | 3(11.5) | 14 (53.8) | |||
| Yes | 23(88.5) | 12 (46.2) | |||
| Spontaneous remission | 26 | 26 | 0.0054 | ||
| No | . | 9(34.6) | . | 19(73.1) | . |
| Yes | . | 17 (65.4) | . | 7(26.9) | . |
* number of patients.
Frequencies (percentage) or medians (interquartile range) are shown. Quantitative variables were compared by a Student’s t-test or a Wilcoxon rank-sum test, and categorical variables were compared by a Pearson's Chi-squaretest or Fisher’s exact test.